Kyle T. Baron, Pharm.D., Ph.D.

Principal Scientist I

Kyle Baron joined MetrumRG in 2010 as a Research Scientist, working with the systems biology group to develop Bayesian hepatitis C viral dymanic models to help quantify antiviral drug effects and predict long-term viral response rates.

Recent publications by this scientist

Population pharmacokinetics and exposure-response (efficacy and safety/tolerability) of empagliflozin in patients with type 2 diabetes

September 1, 2016

Baron KT, Macha S, Broedl UC, Nock V, Retlich S, Riggs M.  Diabetes Ther. 2016 Sep;7(3):455-71.

Download PDF

Comparing the performance of four open-source methods for multiple parameter estimation in a systems pharmacology model

June 1, 2016

Eudy RJ, Riggs MM, Baron K. ┬áPresented at the Sanofi–MSISB Mount Sinai Systems Pharmacology Symposium, June 2016.

Download PDF

Simulation from ODE-based population PK/PD and systems pharmacology models in R with mrgsolve

October 1, 2015

Baron KT and Gastonguay MR.  Presented at the 6th American Conference on Pharmacometrics (ACoP), Arlington, VA; October 2015.

Download PDF